logo
  

Eastman Chemical Q1 Profit Tops Estimate

Eastman Chemical Co. (EMN) reported net income for the first quarter of $171 million or $1.14 per share, compared to $233 million or $1.52 per share for the year-ago quarter.

Excluding items, adjusted earnings per share for the first quarter was $1.84, compared to $1.61 in the prior year quarter.

Sales revenue for the first quarter rose 6% to $2.44 billion from $2.31 billion a year ago.

Analysts polled by Thomson Reuters expected the company to earn $1.60 per share on revenue of $2.56 billion for the first quarter. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT